ImmunityBio Announces Milestone in Large-Scale Production of Enhanced NK Cells for Cancer Research

ImmunityBio Announces Milestone in Large-Scale Production of Enhanced NK Cells for Cancer Research

ImmunityBio shared a post on X:

“We’ve announced a milestone in large-scale production and cryopreservation of memory cytokine-enhanced natural killer (NK) cells from more than 60 healthy and cancer donors, supporting ongoing research in NK cell–based therapies.”

Other articles featuring ImmunityBio on OncoDaily.